Regional Sales Director, West - Neurology

Employer
Celgene
Location
Houston, Texas, United States
Posted
Jan 16, 2019
Ref
1804353-expVer-4
Required Education
Bachelors Degree
Position Type
Full time
Req #: 1804353
Location: Dallas, Texas, United States
Job Category: Sales and Marketing
Work Location: Quadrangle Tower - 2828 Routh St Suite 650 75201
Organization: Regional Sales
Employee Status: Full-time
Job Type: Regular
Other Locations: United States-Arizona-Phoenix, United States-California-Los Angeles, United States-California-San Francisco, United States-Texas-Houston

Celgene is seeking a dynamic Regional Sales Director with proven track record to build and lead the West Region Sales force for our new compound in Multiple Sclerosis. The region will cover all states from Michigan, Indiana, Kentucky, Louisiana west to California, Oregon and Washington.

Responsibilities include, but are not limited to:
  • Meet or exceed sales goals, maximize promotional budgets, and execute the national sales strategy in accordance with Celgene polices.
  • Development and implement area business plan to support the launch of a new product in Neurology.
  • Build a best in class area sales organization, including; sourcing, recruiting, onboarding and training Regional Sales Managers and Neurology Sales Specialists.
  • Develop and sustain an environment consistent with Celgene's Cultural aspirations: Vision, Values, Behaviors, and Purpose.
  • Ensure compliance with all Federal and State regulation, Celgene Polices, and enforce company regulatory guidelines.
  • Identify opportunities in the market place, share best practices, and proactively communicate strategies to cross-functional partners and members of US Leadership Team. Manage implementation of all promotional activities to support sales and marketing strategies, in accordance with Celgene's promotional policies.
  • Consistently collaborate with cross functional field leadership to optimize organizational territory performance.
  • Develop area succession plan to ensure that appropriate talent is in place to achieve long-term business goals and support the growth of the corporation.
  • Act as a player/coach by building and sustaining relationships with Key Opinion Leaders.
  • Coach team members individually to perform as a high functioning unit.
  • Responsible for taking appropriate corrective action when observing and/or reviewing sales and sampling practices that are not accordance with Celgene's expectations, polices, or procedures.
    Skills/Knowledge Preferred:
  • Bachelor's Degree.
  • 10+ years experience within the pharmaceutical, biotechnology or medical industry.
  • 3+ years pharmaceutical sales management experience with document leadership accolades.
  • Management of 8-10 direct reports (Management level).
  • Therapeutic experience in Multiple Sclerosis or competitive Specialty preferred.
  • New drug launch experience preferred.
  • Broad commercial experience, including Marketing, Market Access, or Operations.
  • Demonstrated track record of effective interpersonal skills, ability to provide effective performance feedback, strong written and verbal skills, good presentation skills, sound evaluator of performance, and analytical abilities.
  • Able to travel 50% with overnights stays.
  • Must reside within region boundaries. Preferred locations: Chicago, Minneapolis, Dallas, Houston, Denver, Phoenix, San Diego, Los Angeles, San Francisco or Seattle#LI-POST


About Us

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.